APO Research
Talk to an analyst

APO RESEARCH · REPORT

Giant Cell Arteritis Therapeutic

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Giant Cell Arteritis Therapeutic Industry Growth and Trends Forecast to 2032

22 December 2025111 pages

Choose your research edition.

Industry ResearchGiant Cell Arteritis Therapeutic Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Giant Cell Arteritis Therapeutic Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Giant Cell Arteritis Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Giant Cell Arteritis Therapeutic Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Giant Cell Arteritis Therapeutic Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Giant Cell Arteritis Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Giant Cell Arteritis Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Giant Cell Arteritis Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Giant Cell Arteritis Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Giant Cell Arteritis Therapeutic market include Abbott, Sanofi, Johnson & Johnson Services, Inc., Novartis AG, GlaxoSmithKline plc, AbbVie, Inc., Regeneron, Lahey Clinic Foundation and Kiniksa Pharmaceuticals, Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Giant Cell Arteritis Therapeutic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Giant Cell Arteritis Therapeutic market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Giant Cell Arteritis Therapeutic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Giant Cell Arteritis Therapeutic.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Giant Cell Arteritis Therapeutic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Giant Cell Arteritis Therapeutic Market by Company

Abbott

Sanofi

Johnson & Johnson Services, Inc.

Novartis AG

GlaxoSmithKline plc

AbbVie, Inc.

Regeneron

Lahey Clinic Foundation

Kiniksa Pharmaceuticals, Ltd.

Johns Hopkins Hospital

Fortis Healthcare

F. Hoffmann-La Roche Ltd.

Duke University Health System

Bristol-Myers Squibb Company

American College of Rheumatology

Giant Cell Arteritis Therapeutic Segment by Type

Tocilizumab

Prednisone

Methotrexate

Aspirin

Giant Cell Arteritis Therapeutic Segment by Application

Anticoagulants

Immunosuppressive Agents

Corticosteroids

Others

Giant Cell Arteritis Therapeutic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Giant Cell Arteritis Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Giant Cell Arteritis Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Giant Cell Arteritis Therapeutic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Giant Cell Arteritis Therapeutic companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Giant Cell Arteritis Therapeutic Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Giant Cell Arteritis Therapeutic Market Share by Region (2021-2026) Table 4. Global Giant Cell Arteritis Therapeutic Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Giant Cell Arteritis Therapeutic Market Share by Region (2027-2032) Table 6. Global Giant Cell Arteritis Therapeutic Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Giant Cell Arteritis Therapeutic Market Size Share by Type (2021-2026) Table 9. Global Giant Cell Arteritis Therapeutic Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Giant Cell Arteritis Therapeutic Market Size Share Forecasted by Type (2027-2032) Table 11. North America Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Giant Cell Arteritis Therapeutic Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Giant Cell Arteritis Therapeutic Market Size Share by Application (2021-2026) Table 24. Global Giant Cell Arteritis Therapeutic Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Giant Cell Arteritis Therapeutic Market Size Share Forecasted by Application (2027-2032) Table 26. North America Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Giant Cell Arteritis Therapeutic Industry Trends Table 37. Giant Cell Arteritis Therapeutic Industry Drivers Table 38. Giant Cell Arteritis Therapeutic Industry Opportunities and Challenges Table 39. Giant Cell Arteritis Therapeutic Industry Restraints Table 40. Global Giant Cell Arteritis Therapeutic Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Company (2021-2026) Table 42. Global Giant Cell Arteritis Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Giant Cell Arteritis Therapeutic Key Company Headquarters & Area Served Table 44. Global Giant Cell Arteritis Therapeutic Company, Product Type & Application Table 45. Global Giant Cell Arteritis Therapeutic Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Giant Cell Arteritis Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Giant Cell Arteritis Therapeutic Product Portfolio Table 52. Abbott Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Giant Cell Arteritis Therapeutic Product Portfolio Table 57. Sanofi Recent Development Table 58. Johnson & Johnson Services, Inc. Company Information Table 59. Johnson & Johnson Services, Inc. Business Overview Table 60. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product Portfolio Table 62. Johnson & Johnson Services, Inc. Recent Development Table 63. Novartis AG Company Information Table 64. Novartis AG Business Overview Table 65. Novartis AG Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis AG Giant Cell Arteritis Therapeutic Product Portfolio Table 67. Novartis AG Recent Development Table 68. GlaxoSmithKline plc Company Information Table 69. GlaxoSmithKline plc Business Overview Table 70. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Portfolio Table 72. GlaxoSmithKline plc Recent Development Table 73. AbbVie, Inc. Company Information Table 74. AbbVie, Inc. Business Overview Table 75. AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product Portfolio Table 77. AbbVie, Inc. Recent Development Table 78. Regeneron Company Information Table 79. Regeneron Business Overview Table 80. Regeneron Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Regeneron Giant Cell Arteritis Therapeutic Product Portfolio Table 82. Regeneron Recent Development Table 83. Lahey Clinic Foundation Company Information Table 84. Lahey Clinic Foundation Business Overview Table 85. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Portfolio Table 87. Lahey Clinic Foundation Recent Development Table 88. Kiniksa Pharmaceuticals, Ltd. Company Information Table 89. Kiniksa Pharmaceuticals, Ltd. Business Overview Table 90. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product Portfolio Table 92. Kiniksa Pharmaceuticals, Ltd. Recent Development Table 93. Johns Hopkins Hospital Company Information Table 94. Johns Hopkins Hospital Business Overview Table 95. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Portfolio Table 97. Johns Hopkins Hospital Recent Development Table 98. Fortis Healthcare Company Information Table 99. Fortis Healthcare Business Overview Table 100. Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Fortis Healthcare Giant Cell Arteritis Therapeutic Product Portfolio Table 102. Fortis Healthcare Recent Development Table 103. F. Hoffmann-La Roche Ltd. Company Information Table 104. F. Hoffmann-La Roche Ltd. Business Overview Table 105. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Portfolio Table 107. F. Hoffmann-La Roche Ltd. Recent Development Table 108. Duke University Health System Company Information Table 109. Duke University Health System Business Overview Table 110. Duke University Health System Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Duke University Health System Giant Cell Arteritis Therapeutic Product Portfolio Table 112. Duke University Health System Recent Development Table 113. Bristol-Myers Squibb Company Company Information Table 114. Bristol-Myers Squibb Company Business Overview Table 115. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Portfolio Table 117. Bristol-Myers Squibb Company Recent Development Table 118. American College of Rheumatology Company Information Table 119. American College of Rheumatology Business Overview Table 120. American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. American College of Rheumatology Giant Cell Arteritis Therapeutic Product Portfolio Table 122. American College of Rheumatology Recent Development Table 123. North America Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Giant Cell Arteritis Therapeutic Market Share by Country (2021-2026) Table 126. North America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Giant Cell Arteritis Therapeutic Market Share Forecast by Country (2027-2032) Table 128. Europe Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Giant Cell Arteritis Therapeutic Market Share by Country (2021-2026) Table 131. Europe Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Giant Cell Arteritis Therapeutic Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Giant Cell Arteritis Therapeutic Market Share by Country (2021-2026) Table 136. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Giant Cell Arteritis Therapeutic Market Share Forecast by Country (2027-2032) Table 138. Latin America Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Giant Cell Arteritis Therapeutic Market Share by Country (2021-2026) Table 141. Latin America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Giant Cell Arteritis Therapeutic Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Giant Cell Arteritis Therapeutic Market Share by Country (2021-2026) Table 146. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Giant Cell Arteritis Therapeutic Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Giant Cell Arteritis Therapeutic Product Image Figure 3. Global Giant Cell Arteritis Therapeutic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Giant Cell Arteritis Therapeutic Market Size (2021-2032) & (US$ Million) Figure 5. Global Giant Cell Arteritis Therapeutic Market Share by Region: 2025 VS 2032 Figure 6. Global Giant Cell Arteritis Therapeutic Market Share by Region (2021-2032) Figure 7. North America Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tocilizumab Image Figure 13. Global Tocilizumab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Prednisone Image Figure 15. Global Prednisone Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Methotrexate Image Figure 17. Global Methotrexate Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Aspirin Image Figure 19. Global Aspirin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Giant Cell Arteritis Therapeutic Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Giant Cell Arteritis Therapeutic Market Share by Type 2025 VS 2032 Figure 22. North America Giant Cell Arteritis Therapeutic Market Size Share by Type (2021-2032) Figure 23. Europe Giant Cell Arteritis Therapeutic Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Share by Type (2021-2032) Figure 25. Latin America Giant Cell Arteritis Therapeutic Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Share by Type (2021-2032) Figure 27. Anticoagulants Image Figure 28. Global Anticoagulants Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Immunosuppressive Agents Image Figure 30. Global Immunosuppressive Agents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Corticosteroids Image Figure 32. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Giant Cell Arteritis Therapeutic Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Giant Cell Arteritis Therapeutic Market Share by Application 2025 VS 2032 Figure 37. North America Giant Cell Arteritis Therapeutic Market Size Share by Application (2021-2032) Figure 38. Europe Giant Cell Arteritis Therapeutic Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Share by Application (2021-2032) Figure 40. Latin America Giant Cell Arteritis Therapeutic Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Giant Cell Arteritis Therapeutic Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Giant Cell Arteritis Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Giant Cell Arteritis Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Giant Cell Arteritis Therapeutic Market Share by Country (2021-2032) Figure 47. Europe Giant Cell Arteritis Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Giant Cell Arteritis Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Giant Cell Arteritis Therapeutic Market Share by Country (2021-2032) Figure 50. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Giant Cell Arteritis Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Giant Cell Arteritis Therapeutic Market Share by Country (2021-2032) Figure 53. Latin America Giant Cell Arteritis Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Giant Cell Arteritis Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Giant Cell Arteritis Therapeutic Market Share by Country (2021-2032) Figure 56. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Giant Cell Arteritis Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Giant Cell Arteritis Therapeutic Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Tocilizumab
  • Prednisone
  • Methotrexate
  • Aspirin
Applications
  • Anticoagulants
  • Immunosuppressive Agents
  • Corticosteroids
  • Others
Companies covered
  • Abbott
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • GlaxoSmithKline plc
  • AbbVie, Inc.
  • Regeneron
  • Lahey Clinic Foundation
  • Kiniksa Pharmaceuticals, Ltd.
  • Johns Hopkins Hospital
  • Fortis Healthcare
  • F. Hoffmann-La Roche Ltd.
  • Duke University Health System
  • Bristol-Myers Squibb Company
  • American College of Rheumatology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Giant Cell Arteritis Therapeutic Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Giant Cell Arteritis Therapeutic Market Size by Region (2021-2032)
  5. 1.4.1 Global Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026)
  6. 1.4.2 Global Giant Cell Arteritis Therapeutic Market Size by Region (2027-2032)
  7. 1.5 Key Regions Giant Cell Arteritis Therapeutic Market Size (2021-2032)
  8. 1.5.1 North America Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032)
2 Giant Cell Arteritis Therapeutic Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tocilizumab
  3. 2.1.2 Prednisone
  4. 2.1.3 Methotrexate
  5. 2.1.4 Aspirin
  6. 2.2 Global Giant Cell Arteritis Therapeutic Market Size by Type
  7. 2.2.1 Global Giant Cell Arteritis Therapeutic Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Giant Cell Arteritis Therapeutic Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Giant Cell Arteritis Therapeutic Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Giant Cell Arteritis Therapeutic Market Size by Regions
  11. 2.3.1 North America Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Breakdown by Type (2021-2026)
3 Giant Cell Arteritis Therapeutic Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Anticoagulants
  3. 3.1.2 Immunosuppressive Agents
  4. 3.1.3 Corticosteroids
  5. 3.1.4 Others
  6. 3.2 Global Giant Cell Arteritis Therapeutic Market Size by Application
  7. 3.2.1 Global Giant Cell Arteritis Therapeutic Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Giant Cell Arteritis Therapeutic Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Giant Cell Arteritis Therapeutic Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Giant Cell Arteritis Therapeutic Market Size by Regions
  11. 3.3.1 North America Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Giant Cell Arteritis Therapeutic Industry Trends
  2. 4.2 Giant Cell Arteritis Therapeutic Industry Drivers
  3. 4.3 Giant Cell Arteritis Therapeutic Industry Opportunities and Challenges
  4. 4.4 Giant Cell Arteritis Therapeutic Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Giant Cell Arteritis Therapeutic Revenue (2021-2026)
  2. 5.2 Global Giant Cell Arteritis Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Giant Cell Arteritis Therapeutic Key Company Headquarters & Area Served
  4. 5.4 Global Giant Cell Arteritis Therapeutic Company, Product Type & Application
  5. 5.5 Global Giant Cell Arteritis Therapeutic Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Giant Cell Arteritis Therapeutic Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Giant Cell Arteritis Therapeutic Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Giant Cell Arteritis Therapeutic Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Giant Cell Arteritis Therapeutic Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Giant Cell Arteritis Therapeutic Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson Services, Inc.
  14. 6.3.1 Johnson & Johnson Services, Inc. Company Information
  15. 6.3.2 Johnson & Johnson Services, Inc. Business Overview
  16. 6.3.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product Portfolio
  18. 6.3.5 Johnson & Johnson Services, Inc. Recent Developments
  19. 6.4 Novartis AG
  20. 6.4.1 Novartis AG Company Information
  21. 6.4.2 Novartis AG Business Overview
  22. 6.4.3 Novartis AG Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis AG Giant Cell Arteritis Therapeutic Product Portfolio
  24. 6.4.5 Novartis AG Recent Developments
  25. 6.5 GlaxoSmithKline plc
  26. 6.5.1 GlaxoSmithKline plc Company Information
  27. 6.5.2 GlaxoSmithKline plc Business Overview
  28. 6.5.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Portfolio
  30. 6.5.5 GlaxoSmithKline plc Recent Developments
  31. 6.6 AbbVie, Inc.
  32. 6.6.1 AbbVie, Inc. Company Information
  33. 6.6.2 AbbVie, Inc. Business Overview
  34. 6.6.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie, Inc. Giant Cell Arteritis Therapeutic Product Portfolio
  36. 6.6.5 AbbVie, Inc. Recent Developments
  37. 6.7 Regeneron
  38. 6.7.1 Regeneron Company Information
  39. 6.7.2 Regeneron Business Overview
  40. 6.7.3 Regeneron Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Regeneron Giant Cell Arteritis Therapeutic Product Portfolio
  42. 6.7.5 Regeneron Recent Developments
  43. 6.8 Lahey Clinic Foundation
  44. 6.8.1 Lahey Clinic Foundation Company Information
  45. 6.8.2 Lahey Clinic Foundation Business Overview
  46. 6.8.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Portfolio
  48. 6.8.5 Lahey Clinic Foundation Recent Developments
  49. 6.9 Kiniksa Pharmaceuticals, Ltd.
  50. 6.9.1 Kiniksa Pharmaceuticals, Ltd. Company Information
  51. 6.9.2 Kiniksa Pharmaceuticals, Ltd. Business Overview
  52. 6.9.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product Portfolio
  54. 6.9.5 Kiniksa Pharmaceuticals, Ltd. Recent Developments
  55. 6.10 Johns Hopkins Hospital
  56. 6.10.1 Johns Hopkins Hospital Company Information
  57. 6.10.2 Johns Hopkins Hospital Business Overview
  58. 6.10.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Portfolio
  60. 6.10.5 Johns Hopkins Hospital Recent Developments
  61. 6.11 Fortis Healthcare
  62. 6.11.1 Fortis Healthcare Company Information
  63. 6.11.2 Fortis Healthcare Business Overview
  64. 6.11.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Fortis Healthcare Giant Cell Arteritis Therapeutic Product Portfolio
  66. 6.11.5 Fortis Healthcare Recent Developments
  67. 6.12 F. Hoffmann-La Roche Ltd.
  68. 6.12.1 F. Hoffmann-La Roche Ltd. Company Information
  69. 6.12.2 F. Hoffmann-La Roche Ltd. Business Overview
  70. 6.12.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Portfolio
  72. 6.12.5 F. Hoffmann-La Roche Ltd. Recent Developments
  73. 6.13 Duke University Health System
  74. 6.13.1 Duke University Health System Company Information
  75. 6.13.2 Duke University Health System Business Overview
  76. 6.13.3 Duke University Health System Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Duke University Health System Giant Cell Arteritis Therapeutic Product Portfolio
  78. 6.13.5 Duke University Health System Recent Developments
  79. 6.14 Bristol-Myers Squibb Company
  80. 6.14.1 Bristol-Myers Squibb Company Company Information
  81. 6.14.2 Bristol-Myers Squibb Company Business Overview
  82. 6.14.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Portfolio
  84. 6.14.5 Bristol-Myers Squibb Company Recent Developments
  85. 6.15 American College of Rheumatology
  86. 6.15.1 American College of Rheumatology Company Information
  87. 6.15.2 American College of Rheumatology Business Overview
  88. 6.15.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 American College of Rheumatology Giant Cell Arteritis Therapeutic Product Portfolio
  90. 6.15.5 American College of Rheumatology Recent Developments
7 North America
  1. 7.1 North America Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
  3. 7.3 North America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
  3. 8.3 Europe Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
  3. 10.3 South America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst